MIRA Pharmaceuticals' Shares Soar on Ketamine-Analog Drug Study Results
MIRA Pharmaceuticals' Shares Soar on Ketamine-Analog Drug Study Results
米拉制药公司的股价在氯胺酮类似药物研究结果公布后飙升
Unity Software(U.US) reported fourth-quarter financial results after the market close on Monday. Here's a rundown of the report.Q4 Earnings: Unity said fourth-quarter revenue increased 35% year-over-year to $609 million, beating the consensus estimate of $562.71 million. The company reported a quarterly loss of 66 cents per share.
登录免费看全文
登录/注册